Vasa Therapeutics’ $6 Million Seed Funding Round

Pillsbury Winthrop Shaw Pittman LLP advised Vasa Therapeutics, Inc. on the round.Vasa Therapeutics, Inc., a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, announced the closing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here